Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Caladrius Biosciences Inc (NASDAQ:CLBS)

3.56
Delayed Data
As of 3:59pm ET
 -0.18 / -4.81%
Today’s Change
3.26
Today|||52-Week Range
13.30
-67.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues14.3M14.7M17.9M22.5M
 
 
 
 
 
Cost of Goods Sold10.6M11.6M13.8M17.8M
 
 
 
 
 
Depreciation And Amortization1.6M1.6M2.2M2.7M
 
 
 
 
 
 
Operating ExpensesGross Income2.2M1.5M2.0M2.0M
 
 
 
 
 
General Expenses32.6M38.3M59.7M53.6M
 
 
 
 
 
Research And Development10.4M16.9M29.1M23.8M
 
 
 
 
 
Total Operating Expenses44.7M51.5M75.7M74.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-30.4M-36.8M-57.7M-51.6M
 
 
 
 
 
Extraordinary Credit0.0078.0K3.1M18.3M
 
 
 
 
Extraordinary Charge-4.3M-1.9M---62.3M
 
 
 
 
Interest Expense On Debt1.6M281.4K755.7K2.1M
 
 
 
 
 
Other Expenses0.00207.1K-154.0K-536.4K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-36.3M-38.7M-55.6M-98.3M
 
 
 
 
 
Income Taxes-175.5K-780.1K-104.2K-17.2M
 
 
 
 
 
Minority Interest-287.2K-504.1K-593.3K-124.5K
 
 
 
 
 
Preferred Dividend-528.0K0.000.000.00
 
 
Discontinued Operations-18.0M0.000.000.00
 
 
Net Income-54.8M-39.0M-54.9M-80.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.4M2.0M3.3M4.9M
 
 
 
 
 
Shares To Calculate EPS Diluted1.4M2.0M3.3M4.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$40.00-$19.00-$16.80-$16.70
 
 
 
 
 
EPS Diluted-$40.00-$19.00-$16.80-$16.70